These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18843732)

  • 1. Fetal fibronectin testing for reducing the risk of preterm birth.
    Berghella V; Hayes E; Visintine J; Baxter JK
    Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD006843. PubMed ID: 18843732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal fibronectin testing for reducing the risk of preterm birth.
    Berghella V; Saccone G
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD006843. PubMed ID: 31356681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical assessment by ultrasound for preventing preterm delivery.
    Berghella V; Baxter JK; Hendrix NW
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007235. PubMed ID: 19588421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical assessment by ultrasound for preventing preterm delivery.
    Berghella V; Baxter JK; Hendrix NW
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD007235. PubMed ID: 23440813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
    Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
    Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials.
    Berghella V; Saccone G
    Am J Obstet Gynecol; 2016 Oct; 215(4):431-8. PubMed ID: 27133012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis.
    Deshpande SN; van Asselt AD; Tomini F; Armstrong N; Allen A; Noake C; Khan K; Severens JL; Kleijnen J; Westwood ME
    Health Technol Assess; 2013 Sep; 17(40):1-138. PubMed ID: 24060096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical assessment by ultrasound for preventing preterm delivery.
    Obstet Gynecol; 2009 Nov; 114(5):1140-1141. PubMed ID: 20168118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
    Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity.
    Thinkhamrop J; Hofmeyr GJ; Adetoro O; Lumbiganon P; Ota E
    Cochrane Database Syst Rev; 2015 Jan; 1():CD002250. PubMed ID: 25621770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of quantitative fetal fibronectin for spontaneous preterm birth in asymptomatic pregnancies: a systematic literature review and meta-analysis.
    Ruma MS; Betts M; Dodman S; Neupane B
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2279923. PubMed ID: 37953268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Presence of fetal fibronectin in cervico-vaginal secretion as predictor of premature labor].
    García Alonso A; Ayala Méndez JA; Izquierdo Puente JC; Jiménez Solís G; Sánchez Martínez M
    Ginecol Obstet Mex; 1999 Jan; 67():23-8. PubMed ID: 10085606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fetal fibronectin--biomarker for preterm labour].
    Akush Ginekol (Sofiia); 2010; 49(2):39-42. PubMed ID: 20734676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of fetal fibronectin testing compared with digital cervical assessment of women with preterm contractions.
    Mateus J; Pereira L; Baxter J; Berghella V; Tolosa J
    Am J Perinatol; 2007 Jun; 24(6):381-5. PubMed ID: 17566945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elective preterm birth for fetal gastroschisis.
    Grant NH; Dorling J; Thornton JG
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD009394. PubMed ID: 23737031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational age at cervical length and fetal fibronectin assessment and the incidence of spontaneous preterm birth in twins.
    Fox NS; Saltzman DH; Fishman A; Klauser CK; Gupta S; Rebarber A
    J Ultrasound Med; 2015 Jun; 34(6):977-84. PubMed ID: 26014316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women.
    Jun SY; Lee JY; Kim HM; Kim MJ; Cha HH; Seong WJ
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):241. PubMed ID: 31296172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor.
    Ravi M; Beljorie M; El Masry K
    J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3909-3914. PubMed ID: 29807458
    [No Abstract]   [Full Text] [Related]  

  • 19. Antenatal dietary advice and supplementation to increase energy and protein intake.
    Ota E; Tobe-Gai R; Mori R; Farrar D
    Cochrane Database Syst Rev; 2012 Sep; (9):CD000032. PubMed ID: 22972038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal administration of progesterone for preventing preterm birth.
    Dodd JM; Flenady V; Cincotta R; Crowther CA
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004947. PubMed ID: 16437505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.